Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activity
US-2025092027-A1 · Mar 20, 2025 · US
This page is not indexed by search engines while we improve data quality.
Cons Benjamin David patents
Cons Benjamin David is listed as an inventor on 16 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Cons Benjamin David |
| Total patents | 16 |
| First publication | Jan 17, 2019 |
| Latest publication | Mar 20, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Isoindolinone inhibitors of the mdm2-p53 interaction and process for making them
US-2025074900-A1 · Mar 6, 2025 · US
Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them
US-12077526-B2 · Sep 3, 2024 · US
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
US-12071429-B2 · Aug 27, 2024 · US
Isoindolinone inhibitors of the mdm2-p53 interaction and process for making them
US-2023278989-A1 · Sep 7, 2023 · US
Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activity
US-2022106287-A1 · Apr 7, 2022 · US
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
US-11261171-B1 · Mar 1, 2022 · US
Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activity
US-2021276984-A1 · Sep 9, 2021 · US
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
US-10981898-B2 · Apr 20, 2021 · US
Isoindolinone inhibitors of the mdm2-p53 interaction and process for making them
US-2021101887-A1 · Apr 8, 2021 · US
Recent patents
Latest publications not already listed above.
Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activity
US-2020247789-A2 · Aug 6, 2020 · US
Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activity
US-2020079761-A1 · Mar 12, 2020 · US
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
US-10544132-B2 · Jan 28, 2020 · US
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
US-10526311-B2 · Jan 7, 2020 · US
Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activity
US-2019055215-A1 · Feb 21, 2019 · US
Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activity
US-2019016708-A1 · Jan 17, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Astex Therapeutics Ltd | 16 |
| Cancer Research Tech Ltd | 16 |
| Astex Therapeuctics Ltd | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 16 |
| C07D405/14 | 12 |
| C07D401/06 | 12 |
| C07B2200/05 | 12 |
| C07D403/06 | 12 |